The above study demonstrated that USP39 is involved in the regulatory network of malignant progression of pancreatic cancer, and the phenomenon of inhibiting tumor progression by suppressing the expression of USP39 suggests that USP39 may be a potential therapeutic target for pancreatic cancer. This evidence concerns the gene USP39 and familial pancreatic carcinoma.